DONALD E. BOBO JR - 08 Sep 2022 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Role: CVP,Strategy/Corp Development
Signature: Linda J. Park, Attorney-in-Fact
Issuer symbol: EW
Transactions as of: 08 Sep 2022
Transactions value $: -$374,874
Form type: 4
Filing time: 08 Sep 2022, 17:49:05 UTC
Previous filing: 09 Aug 2022
Next filing: 11 Oct 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EW	Common Stock	Options Exercise	$236,697	+6,725	+11%	$35.2	69,285	08 Sep 2022	Direct	F1
transaction	EW	Common Stock	Sale	-$611,571	-6,725	-9.7%	$90.94	62,560	08 Sep 2022	Direct	F1
holding	EW	Common Stock						38,267	08 Sep 2022	401(k)
holding	EW	Common Stock						117,320	08 Sep 2022	By Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	EW	Employee Stock Option (Right to Acquire)	Options Exercise	$0	-6,725	-12%	$0	47,075	08 Sep 2022	Common Stock	6,725	$35.2	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 25, 2022.

Remarks:

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person.